Where to buy ibrutinib/ibrutinib in India

Ibrutinib/Ibrutinib has an Indian version, which belongs to the category of generic ibrutinib drugs. There may be multiple pharmaceutical companies in India producing different versions of ibrutinib, including the Indian natco version. These versions may differ in price, but in terms of drug ingredients, they will remain basically the same as those of the original drug. The specific price may fluctuate due to market supply and demand, drug specifications, etc.

Ibrutinib is an antineoplastic agent used to treat chronic lymphocytic leukemia (CLL), mantle cell lymphoma, and Waldenström macroglobulinemia. In the case of chronic lymphocytic leukemia, ibrutinib is a breakthrough treatment option for patients with this disease. Given its excellent toxicity profile, it may be a suitable option for patients with contraindications to chemotherapy (i.e., advanced age, multiple comorbidities, poor health status). Published clinical trials have shown that ibrutinib is highly active in the treatment of relapsed/refractory CLL and induces durable remissions in heavily pretreated elderly patients with high-risk disease features.

The Indian version of ibrutinib generics may currently only be sold in local hospitals or pharmacies. SpecificationsThe price of each box of 140mg*30 tablets may be several hundred yuan (the price may fluctuate due to exchange rate effects). Patients should purchase and use any drug including ibrutinib under the guidance of a doctor. At the same time, since different versions of ibrutinib may have differences in quality and effectiveness, it is very important to choose formal channels to purchase and follow your doctor’s recommendations. For more information on overseas drug prices and related information, please consult Yaode Medical Consultants.